Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports


The Plantbased Vaccines Market is estimated to witness stupendous growth in the years to come. AI is already into the disruption mode regarding the healthcare vertical. Machine learning is used for displaying the relevant info about health in the mobile app. The application of AI in healthcare is better known as “Augmented Intelligence”. This would be the running trend in the healthcare vertical in the upcoming period.

Market Overview

Plant genetic engineering has developed dramatically over the past decade that have facilitated in the development of plant-based vaccines. However, plant-based vaccines have not yet been commercialized. A number of plants have been used in the past few years to attempt the development of plant-based vaccines including rice, maize, potato, carrot, tobacco, lettuce, alfalfa, tomato, peanut, and soybean.

To remain ‘ahead’ of your competitors, request for a sample @

Choice of plant for the production of plant-based vaccine determines the route of administration of the vaccine, since some plants and its products cannot be consumed directly. Thus the development of plant-based vaccines have to take into account the heat or pressure treatments. Cereal crops are one of the most attractive type of plant for the production of plant-based vaccines since the vaccine produced in seeds are most stable over long storage periods.

Currently the only plant-based vaccine approved is that for Newcastle disease vaccine for poultry. Although, plant-based vaccines are not quite ready for humans in the primetime, there are a number of clinical trials ongoing.

Research in plant-based vaccine for influenza has seen some success in the past few years probably because the haemagglutinin (HA) protein can be well expressed in plants and can undergo proper post translational folding.

Plant-based vaccines have several advantages including cheap and large scale production, readily accepted by patients and stable for long term storage of the antigen. Plant-based vaccines could be one of the best methods for reducing the burden of infectious diseases globally.

Additionally, unlike traditional vaccines, plant-based vaccines contamination with plant virus would have a negligible likelihood of adverse effect on humans. The positives of plant-based vaccines are outweighed by the negative factors such as allergic reactions, and risk of escaping the lab resulting in unforeseen consequences that may hinder the approval and growth of the plant-based vaccines market.

Pre-Book Right Now for Exclusive Analyst Support @


Market Segmentation

Based on the vaccine type
  • Bacterial Vaccine
  • Viral Vaccine
  • Others
Based on the plant type
  • Tobacco
  • Potato
  • Maize
  • Others
Based on the application
  • Influenza
  • Zika Virus
  • Ebola Virus
  • Others


Get a Customized Scope to Match Your Need Ask an Expert-

Regional Outlook

North America Plant-based Vaccines market is expected to hold the maximum market together in the global Plant-based Vaccines market. This is due to a large number of plant-based vaccine manufacturers located in the region with state of the art production facility in states such as Texas.

Emerging regions such as Africa and Asia Pacific are anticipated to have a higher revenue opportunity owing to the efforts of government, non-profit organizations and the WHO for the development of plant-based vaccines to cater to the unmet needs of the regions.

Market Research Methodology – Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Key Players

A number of plant-based vaccines are being developed and are undergoing clinical trials. Many companies are collaborating with institutes for the development of plant-based vaccines. Some of the key plant-based vaccines industry players include, Medicago, Inc., iBio, Inc., Creative Biolabs, Fraunhofer CMB, EEA Consulting Engineers (Caliber Biotherapeutics), and Icon Genetics- GmbH.

To receive an extensive list of important regions, ask for a Table of Content

About Us: – Persistence Market Research

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –


Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts